Terms: = Colorectal cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Prognosis
44 results:
1. Pharmacological modulation of rb1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer.
Yu Z; Deng P; Chen Y; Lin D; Liu S; Hong J; Guan P; Chen J; Zhong ME; Chen J; Chen X; Sun Y; Wang Y; Wang P; Cai Z; Chan JY; Huang Y; Xiao R; Guo Y; Zeng X; Wang W; Zou Y; Yu Q; Lan P; Teh BT; Wu X; Tan J
Proc Natl Acad Sci U S A; 2024 Feb; 121(6):e2304619121. PubMed ID: 38289962
[TBL] [Abstract] [Full Text] [Related]
2. Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis.
Li N; Lin P; Zuo Z; You MJ; Shuai W; Orlowski R; Manasanch EE; Li S; Xu J; Garces S; Jelloul FZ; Tang Z; Wang W; Medeiros LJ; Yin CC
Cancer Med; 2023 Jul; 12(13):14293-14304. PubMed ID: 37212518
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis.
Centonze G; Maisonneuve P; Prinzi N; Pusceddu S; Albarello L; Pisa E; Barberis M; Vanoli A; Spaggiari P; Bossi P; Cattaneo L; Sabella G; Solcia E; La Rosa S; Grillo F; Tagliabue G; Scarpa A; Papotti M; Volante M; Mangogna A; Del Gobbo A; Ferrero S; Rolli L; Roca E; Bercich L; Benvenuti M; Messerini L; Inzani F; Pruneri G; Busico A; Perrone F; Tamborini E; Pellegrinelli A; Kankava K; Berruti A; Pastorino U; Fazio N; Sessa F; Capella C; Rindi G; Milione M
Neuroendocrinology; 2023; 113(4):457-469. PubMed ID: 36417840
[TBL] [Abstract] [Full Text] [Related]
4. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
Li K; Liu Y; Han J; Gui J; Zhang X
Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
[TBL] [Abstract] [Full Text] [Related]
5. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract] [Full Text] [Related]
6. Artificial intelligence-driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi-center integration analysis.
Xu H; Liu Z; Weng S; Dang Q; Ge X; Zhang Y; Ren Y; Xing Z; Chen S; Zhou Y; Ren J; Han X
Mol Oncol; 2022 Dec; 16(22):4023-4042. PubMed ID: 36083778
[TBL] [Abstract] [Full Text] [Related]
7. ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple cancer Types.
Tan F
Mini Rev Med Chem; 2023; 23(1):88-98. PubMed ID: 35578882
[TBL] [Abstract] [Full Text] [Related]
8. Novel Nexus with NFκB, β-catenin, and rb1 empowers PSMD10/Gankyrin to counteract TNF-α induced apoptosis establishing its oncogenic role.
Mulla SW; Venkatraman P
Int J Biochem Cell Biol; 2022 May; 146():106209. PubMed ID: 35378311
[TBL] [Abstract] [Full Text] [Related]
9. Silence of ATAD2 inhibits proliferation of colorectal carcinoma via the Rb-E2F1 signaling.
Wang JH; Yu TT; Li Y; Hao YP; Han L; Xu KY; Xu P
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6055-6063. PubMed ID: 32572920
[TBL] [Abstract] [Full Text] [Related]
10. New addiction to the NRF2-related factor NRF3 in cancer cells: Ubiquitin-independent proteolysis through the 20S proteasome.
Kobayashi A; Waku T
Cancer Sci; 2020 Jan; 111(1):6-14. PubMed ID: 31742837
[TBL] [Abstract] [Full Text] [Related]
11. The Prognostic Value of G1 Cyclins, p21 and Rb Protein in Patients With Colon cancer.
Palaiologos P; Chrysikos D; Theocharis S; Kouraklis G
Anticancer Res; 2019 Nov; 39(11):6291-6297. PubMed ID: 31704859
[TBL] [Abstract] [Full Text] [Related]
12. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.
Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H
Int J Clin Oncol; 2020 Jan; 25(1):110-117. PubMed ID: 31407167
[TBL] [Abstract] [Full Text] [Related]
13. Human UTP14a promotes angiogenesis through upregulating PDGFA expression in colorectal cancer.
Ren P; Sun X; Zhang C; Wang L; Xing B; Du X
Biochem Biophys Res Commun; 2019 May; 512(4):871-876. PubMed ID: 30929921
[TBL] [Abstract] [Full Text] [Related]
14. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma.
Shamir ER; Devine WP; Pekmezci M; Umetsu SE; Krings G; Federman S; Cho SJ; Saunders TA; Jen KY; Bergsland E; Jones K; Kim GE; Kakar S; Chiu CY; Joseph NM
Mod Pathol; 2019 Feb; 32(2):290-305. PubMed ID: 30237525
[TBL] [Abstract] [Full Text] [Related]
15. Role of ferroptosis in hepatocellular carcinoma.
Nie J; Lin B; Zhou M; Wu L; Zheng T
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2329-2337. PubMed ID: 30167889
[TBL] [Abstract] [Full Text] [Related]
16. Molecular subtype classification of urothelial carcinoma in Lynch syndrome.
Therkildsen C; Eriksson P; Höglund M; Jönsson M; Sjödahl G; Nilbert M; Liedberg F
Mol Oncol; 2018 Aug; 12(8):1286-1295. PubMed ID: 29791078
[TBL] [Abstract] [Full Text] [Related]
17. Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis.
Milione M; Maisonneuve P; Pellegrinelli A; Grillo F; Albarello L; Spaggiari P; Vanoli A; Tagliabue G; Pisa E; Messerini L; Centonze G; Inzani F; Scarpa A; Papotti M; Volante M; Sessa F; Fazio N; Pruneri G; Rindi G; Solcia E; La Rosa S; Capella C
Endocr Relat Cancer; 2018 May; 25(5):583-593. PubMed ID: 29592868
[TBL] [Abstract] [Full Text] [Related]
18. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
[TBL] [Abstract] [Full Text] [Related]
19. [Appropriate Range of Lymph Node Dissection in Elderly Patients with colorectal cancer].
Tsuchida K; Saeki H; Takahashi S; Kamioka Y; Watanabe H; Nakazono M; Kato A; Nagasawa S; Numata K; Osawa H; Matsukawa H; Rino Y; Masuda M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1211-1213. PubMed ID: 29394584
[TBL] [Abstract] [Full Text] [Related]
20. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
[TBL] [Abstract] [Full Text] [Related]
[Next]
